The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.
Endocannabinoids and the regulation of their levels in health and disease
Abstract
PURPOSE OF REVIEW: Endocannabinoids are defined as endogenous agonists of cannabinoid receptors, that is, of the two G-protein-coupled receptors for the Cannabis psychoactive principle Delta-tetra-hydrocannabinol. Two such endogenous mediators have been most thoroughly studied so far: anandamide and 2-arachidonoylglycerol. Here we review the mechanisms for the regulation of their levels under physiological and pathological conditions, and recent findings on their role in disease. RECENT FINDINGS: It is becoming increasingly clear that, although both anandamide and 2-arachidonoyl-glycerol are produced and degraded 'on demand', the levels of these two compounds appear to be regulated in different, and sometimes even opposing, ways, often using redundant molecular mechanisms. Alterations of endocannabinoid levels have been found in both animal models of pain, neurological and neurodegenerative states, gastrointestinal disorders and inflammatory conditions, and in blood, cerebrospinal fluid and bioptic samples from patients with various diseases. SUMMARY: Endocannabinoid levels appear to be transiently elevated as an adaptive reaction to re-establish normal homeostasis when this is acutely and pathologically perturbed. In some chronic conditions, however, this system also contributes to the progress or symptoms of the disorder. As a consequence, new therapeutic drugs are being designed from both stimulants and blockers of endocannabinoid action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,587
Self-citationLeptin-regulated endocannabinoids are involved in maintaining food intake
Di Marzo, V., Goparaju, S. K., Wang, L., Liu, J., Bátkai, S., Járai, Z., Fezza, F., Miura, G. I., Palmiter, R. D., Sugiura, T., et al. (2001) · Nature · doi:10.1038/35071088 · Cited by 1,559
Van Gaal, L. F., Rissanen, A. M., Scheen, A. J., Ziegler, O., & Rössner, S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66374-x · Cited by 1,499
Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia
Després, J.-P., Golay, A., & Sjöström, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044537 · Cited by 1,392
Modulation of anxiety through blockade of anandamide hydrolysis
Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293
Endocannabinoid Signaling in the Brain
Wilson, R. I., & Nicoll, R. A. (2002) · Science · doi:10.1126/science.1063545 · Cited by 1,260
Pi-Sunyer, F. X., Aronne, L. J., Heshmati, H. M., Devin, J., Rosenstock, J., & RIO-North America Study Group, F. T. (2006) · JAMA · doi:10.1001/jama.295.7.761 · Cited by 1,218
CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity
Marsicano, G., Goodenough, S., Monory, K., Hermann, H., Eder, M., Cannich, A., Azad, S. C., Cascio, M. G., Gutiérrez, S. O., van der Stelt, M., et al. (2003) · Science · doi:10.1126/science.1088208 · Cited by 1,208
Self-citationBisogno, T., Howell, F., Williams, G., Minassi, A., Cascio, M. G., Ligresti, A., Matias, I., Schiano-Moriello, A., Paul, P., Williams, E.-J., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200305129 · Cited by 1,039
Self-citationMolecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners
Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T., & Ueda, N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306642200 · Cited by 805
Ramírez, B. G., Blázquez, C., del Pulgar, T. G., Guzmán, M., & de Ceballos, M. L. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4540-04.2005 · Cited by 785
Endocannabinoid control of food intake and energy balance
Di Marzo, V., & Matias, I. (2005) · Nature Neuroscience · doi:10.1038/nn1457 · Cited by 743
Self-citationScheen, A. J., Finer, N., Hollander, P., Jensen, M. D., & Van Gaal, L. F. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69571-8 · Cited by 736
Activation of the peripheral endocannabinoid system in human obesity
Engeli, S., Böhnke, J., Feldpausch, M., Gorzelniak, K., Janke, J., Bátkai, S., Pacher, P., Harvey-White, J., Luft, F. C., Sharma, A. M., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.10.2838 · Cited by 686
Matias, I., Gonthier, M.-P., Orlando, P., Martiadis, V., De Petrocellis, L., Cervino, C., Petrosino, S., Hoareau, L., Festy, F., Pasquali, R., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2679 · Cited by 656
Self-citationCannabinoid physiology and pharmacology: 30 years of progress
Howlett, A. C., Breivogel, C. S., Childers, S. R., Deadwyler, S. A., Hampson, R. E., & Porrino, L. J. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.07.030 · Cited by 608
Bensaid, M., Gary-Bobo, M., Esclangon, A., Maffrand, J. P., Le Fur, G., Oury-Donat, F., & Soubrié, P. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.4.908 · Cited by 593
Gulyas, A. I., Cravatt, B. F., Bracey, M. H., Dinh, T. P., Piomelli, D., Boscia, F., & Freund, T. F. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03428.x · Cited by 561
Peripheral cannabinoid receptor, CB2, regulates bone mass
Ofek, O., Karsak, M., Leclerc, N., Fogel, M., Frenkel, B., Wright, K., Tam, J., Attar-Namdar, M., Kram, V., Shohami, E., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504187103 · Cited by 536
CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis
Teixeira-Clerc, F., Julien, B., Grenard, P., Van Nhieu, J. T., Deveaux, V., Li, L., Serriere-Lanneau, V., Ledent, C., Mallat, A., & Lotersztajn, S. (2006) · Nature Medicine · doi:10.1038/nm1421 · Cited by 528
Molecular Composition of the Endocannabinoid System at Glutamatergic Synapses
Katona, I., Urbán, G. M., Wallace, M., Ledent, C., Jung, K.-M., Piomelli, D., Mackie, K., & Freund, T. F. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0309-06.2006 · Cited by 511
Ibrahim, M. M., Deng, H., Zvonok, A., Cockayne, D. A., Kwan, J., Mata, H. P., Vanderah, T. W., Lai, J., Porreca, F., Makriyannis, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834309100 · Cited by 491
It could be habit forming: drugs of abuse and striatal synaptic plasticity
Gerdeman, G. L., Partridge, J. G., Lupica, C. R., & Lovinger, D. M. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00065-1 · Cited by 480
The endocannabinoid system: a general view and latest additions
Petrocellis, L. D., Cascio, M. G., & Marzo, V. D. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705666 · Cited by 475
A biosynthetic pathway for anandamide
Liu, J., Wang, L., Harvey-White, J., Osei-Hyiaman, D., Razdan, R., Gong, Q., Chan, A. C., Zhou, Z., Huang, B. X., Kim, H.-Y., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601832103 · Cited by 470
Antifibrogenic role of the cannabinoid receptor CB2 in the liver
Julien, B., Grenard, P., Teixeira-Clerc, F., Van Nhieu, J. T., Li, L., Karsak, M., Zimmer, A., Mallat, A., & Lotersztajn, S. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.050 · Cited by 470
The endogenous cannabinoid system protects against colonic inflammation
Massa, F., Marsicano, G., Hermann, H., Cannich, A., Monory, K., Cravatt, B. F., Ferri, G.-L., Sibaev, A., Storr, M., & Lutz, B. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19465 · Cited by 460
Fegley, D., Gaetani, S., Duranti, A., Tontini, A., Mor, M., Tarzia, G., & Piomelli, D. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.078980 · Cited by 427
Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor.
Sánchez, C., CEBALLOS, M. L. D., del Pulgar, T. G., Rueda, D., Corbacho, C., Velasco, G., Galve‐Roperh, I., Huffman, J. W., y Cajal, S. R., & Guzmán, M. (2001) · Cancer Research · Cited by 422
Wallace, M. J., Blair, R. E., Falenski, K. W., Martin, B. R., & DeLorenzo, R. J. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.051920 · Cited by 393
A Second Fatty Acid Amide Hydrolase with Variable Distribution among Placental Mammals
Wei, B. Q., Mikkelsen, T. S., McKinney, M. K., Lander, E. S., & Cravatt, B. F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606646200 · Cited by 363
Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors
Idris, A. I., van 't Hof, R. J., Greig, I. R., Ridge, S. A., Baker, D., Ross, R. A., & Ralston, S. H. (2005) · Nature Medicine · doi:10.1038/nm1255 · Cited by 356
Simon, G. M., & Cravatt, B. F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604660200 · Cited by 356
A missense mutation in human fatty acid amide hydrolase associated with problem drug use
Sipe, J. C., Chiang, K., Gerber, A. L., Beutler, E., & Cravatt, B. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082235799 · Cited by 355
Cannabinoids and neuroinflammation
Walter, L., & Stella, N. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705667 · Cited by 336
Carrier, E. J., Kearn, C. S., Barkmeier, A. J., Breese, N. M., Yang, W., Nithipatikom, K., Pfister, S. L., Campbell, W. B., & Hillard, C. J. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.4.999 · Cited by 336
Tsuboi, K., Sun, Y.-X., Okamoto, Y., Araki, N., Tonai, T., & Ueda, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413473200 · Cited by 332
Lichtman, A. H., Leung, D., Shelton, C. C., Saghatelian, A., Hardouin, C., Boger, D. L., & Cravatt, B. F. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.069401 · Cited by 328
Yoshida, T., Fukaya, M., Uchigashima, M., Miura, E., Kamiya, H., Kano, M., & Watanabe, M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0054-06.2006 · Cited by 327
Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in Hypertension
Bátkai, S., Pacher, P., Osei-Hyiaman, D., Radaeva, S., Liu, J., Harvey-White, J., Offertáler, L., Mackie, K., Rudd, M. A., Bukoski, R. D., et al. (2004) · Circulation · doi:10.1161/01.cir.0000143230.23252.d2 · Cited by 322
Assignment of Endogenous Substrates to Enzymes by Global Metabolite Profiling
Saghatelian, A., Trauger, S. A., Want, E. J., Hawkins, E. G., Siuzdak, G., & Cravatt, B. F. (2004) · Biochemistry · doi:10.1021/bi0480335 · Cited by 316
Hashimotodani, Y., Ohno-Shosaku, T., Tsubokawa, H., Ogata, H., Emoto, K., Maejima, T., Araishi, K., Shin, H.-S., & Kano, M. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.004 · Cited by 315
Di Marzo, V., Bisogno, T., De Petrocellis, L., Melck, D., Orlando, P., Wagner, J. A., & Kunos, G. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00631.x · Cited by 296
Self-citationMaione, S., Bisogno, T., de Novellis, V., Palazzo, E., Cristino, L., Valenti, M., Petrosino, S., Guglielmotti, V., Rossi, F., & Marzo, V. D. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.093286 · Cited by 294
Self-citationvan der Stelt, M., & Di Marzo, V. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.101 · Cited by 291
Self-citationChiang, K. P. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh216 · Cited by 278
Monteleone, P., Matias, I., Martiadis, V., De Petrocellis, L., Maj, M., & Di Marzo, V. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300695 · Cited by 271
Self-citationOverweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH)
Sipe, J. C., Waalen, J., Gerber, A., & Beutler, E. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802954 · Cited by 259
Melis, M., Perra, S., Muntoni, A. L., Pillolla, G., Lutz, B., Marsicano, G., Di Marzo, V., Gessa, G. L., & Pistis, M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3502-04.2004 · Cited by 253
Self-citationBerger, A., Crozier, G., Bisogno, T., Cavaliere, P., Innis, S., & Di Marzo, V. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101119098 · Cited by 247
Self-citationInhibition of Inflammatory Hyperalgesia by Activation of Peripheral CB2Cannabinoid Receptors
Quartilho, A., Mata, H. P., Ibrahim, M. M., Vanderah, T. W., Porreca, F., Makriyannis, A., & Malan, T. P. (2003) · Anesthesiology · doi:10.1097/00000542-200310000-00031 · Cited by 242
SUN, Y.-X., TSUBOI, K., OKAMOTO, Y., TONAI, T., MURAKAMI, M., KUDO, I., & UEDA, N. (2004) · Biochemical Journal · doi:10.1042/bj20040031 · Cited by 235
Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus
Makara, J. K., Mor, M., Fegley, D., Szabó, S. I., Kathuria, S., Astarita, G., Duranti, A., Tontini, A., Tarzia, G., Rivara, S., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1521 · Cited by 232
Fegley, D., Kathuria, S., Mercier, R., Li, C., Goutopoulos, A., Makriyannis, A., & Piomelli, D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400997101 · Cited by 230
Dinh, T. P., Kathuria, S., & Piomelli, D. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.002071 · Cited by 229
CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia
Ujike, H., Takaki, M., Nakata, K., Tanaka, Y., Takeda, T., Kodama, M., Fujiwara, Y., Sakai, A., & Kuroda, S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001029 · Cited by 228
Functional disassociation of the central and peripheral fatty acid amide signaling systems
Cravatt, B. F., Saghatelian, A., Hawkins, E. G., Clement, A. B., Bracey, M. H., & Lichtman, A. H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401292101 · Cited by 225
Alexander, J. P., & Cravatt, B. F. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.08.011 · Cited by 225
van der Stelt, M., Mazzola, C., Esposito, G., Matias, I., Petrosino, S., Filippis, D. D., Micale, V., Steardo, L., Drago, F., Iuvone, T., et al. (2006) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-006-6037-3 · Cited by 224
Self-citationD'Argenio, G., Valenti, M., Scaglione, G., Cosenza, V., Sorrentini, I., & Di Marzo, V. (2006) · The FASEB Journal · doi:10.1096/fj.05-4943fje · Cited by 222
Self-citationCaffarel, M. M., Sarrió, D., Palacios, J., Guzmán, M., & Sánchez, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4566 · Cited by 221
Cannabinoid receptor type 2 gene is associated with human osteoporosis
Karsak, M., Cohen-Solal, M., Freudenberg, J., Ostertag, A., Morieux, C., Kornak, U., Essig, J., Erxlebe, E., Bab, I., Kubisch, C., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi370 · Cited by 219
Pisani, A., Fezza, F., Galati, S., Battista, N., Napolitano, S., Finazzi‐Agrò, A., Bernardi, G., Brusa, L., Pierantozzi, M., Stanzione, P., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20462 · Cited by 213
van der Stelt, M., Fox, S. H., Hill, M., Crossman, A. R., Petrosino, S., Di Marzo, V., & Brotchie, J. M. (2005) · The FASEB Journal · doi:10.1096/fj.04-3010fje · Cited by 199
Self-citationHoffman, A. F., Oz, M., Caulder, T., & Lupica, C. R. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-12-04815.2003 · Cited by 193
Cannabis, cannabinoids and reproduction
Park, B., McPartland, J. M., & Glass, M. (2004) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.04.007 · Cited by 192
P2X7receptors control 2-arachidonoylglycerol production by microglial cells
Witting, A., Walter, L., Wacker, J., Möller, T., & Stella, N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306707101 · Cited by 187
Portella, G., Laezza, C., Laccetti, P., De Petrocellis, L., Di Marzo, V., & Bifulco, M. (2003) · The FASEB Journal · doi:10.1096/fj.02-1129fje · Cited by 184
Self-citationCannabinoid receptor gene (CNR1): association with IV drug use
Comings, D. E., Muhleman, D., Gade, R., Johnson, P., Verde, R., Saucier, G., & MacMurray, J. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000247 · Cited by 175
Anandamide, an endogenous cannabinomimetic eicosanoid: ‘Killing two birds with one stone’
Di Marzo, V., & Fontana, A. (1995) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(95)90077-2 · Cited by 170
Self-citationPlant, Synthetic, and Endogenous Cannabinoids in Medicine
Marzo, V. D., & Petrocellis, L. D. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.57.011205.135648 · Cited by 169
Watanabe, S., Doshi, M., & Hamazaki, T. (2003) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(03)00056-5 · Cited by 168
Cardiovascular Pharmacology of Cannabinoids
Pacher, P., Bátkai, S., & Kunos, G. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_20 · Cited by 167
Identification of a high-affinity binding site involved in the transport of endocannabinoids
Moore, S. A., Nomikos, G. G., Dickason-Chesterfield, A. K., Schober, D. A., Schaus, J. M., Ying, B.-P., Xu, Y.-C., Phebus, L., Simmons, R. M. A., Li, D., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507470102 · Cited by 165
Bilsland, L. G., Dick, J. R. T., Pryce, G., Petrosino, S., Di Marzo, V., Baker, D., Greensmith, L., Bilsland, L. G., Dick, J. R. T., Pryce, G., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-4743fje · Cited by 164
Self-citationBisogno, T., Melck, D., De Petrocellis, L., & Di Marzo, V. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722113.x · Cited by 162
Self-citationInvolvement of Neuronal Cannabinoid Receptor CB1 in Regulation of Bone Mass and Bone Remodeling
Tam, J., Ofek, O., Fride, E., Ledent, C., Gabet, Y., Müller, R., Zimmer, A., Mackie, K., Mechoulam, R., Shohami, E., et al. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026435 · Cited by 162
Fatty acid amide hydrolase deficiency limits early pregnancy events
Wang, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28621 · Cited by 160
Barnes, M. P. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.5.607 · Cited by 159
Saario, S. M., Salo, O. M. H., Nevalainen, T., Poso, A., Laitinen, J. T., Järvinen, T., & Niemi, R. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.04.013 · Cited by 158
A new strategy to block tumor growth by inhibiting endocannabinoid inactivation
Bifulco, M., Laezza, C., Valenti, M., Ligresti, A., Portella, G., & Marzo, V. D. (2004) · The FASEB Journal · doi:10.1096/fj.04-1754fje · Cited by 154
Association of a CB1 Cannabinoid Receptor Gene (CNR1) polymorphism with severe alcohol dependence
Schmidt, L. G., Samochowiec, J., Finckh, U., Fiszer-Piosik, E., Horodnicki, J., Wendel, B., Rommelspacher, H., & Hoehe, M. R. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00164-8 · Cited by 154
Kim, K., Moore, D. H., Makriyannis, A., & Abood, M. E. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.05.025 · Cited by 153
Cannabinoids and cancer: pros and cons of an antitumour strategy
Bifulco, M., Laezza, C., Pisanti, S., & Gazzerro, P. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706632 · Cited by 153
Further evidence for the existence of a specific process for the membrane transport of anandamide
Ligresti, A., Morera, E., van der Stelt, M., Monory, K., Lutz, B., Ortar, G., & Marzo, V. D. (2004) · Biochemical Journal · doi:10.1042/bj20031812 · Cited by 149
Szabó, B., Urbanski, M. J., Bisogno, T., Marzo, V. D., Mendiguren, A., Baer, W. U., & Freiman, I. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.119362 · Cited by 142
Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain
Valenti, M., Vigan�, D., Casico, M. G., Rubino, T., Steardo, L., Parolaro, D., & Marzo, V. D. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3453-5 · Cited by 139
Cabranes, A., Venderová, K., de Lago, E., Fezza, F., Sánchez, A., Mestre, L., Valenti, M., García‐Merino, A., Ramos, J. A., Marzo, V. D., et al. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.03.002 · Cited by 139
Barna, I., Zelena, D., Arszovszki, A. C., & Ledent, C. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.06.006 · Cited by 136
Fatty Acid Amide Hydrolase Controls Mouse Intestinal Motility In Vivo
Capasso, R., Matias, I., Lutz, B., Borrelli, F., Capasso, F., Marsicano, G., Mascolo, N., Petrosino, S., Monory, K., Valenti, M., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.06.018 · Cited by 136
Self-citationPharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis
Mestre, L., Correa, F., Arévalo‐Martín, Á., Molina‐Holgado, E., Valenti, M., Ortar, G., Marzo, V. D., & Guaza, C. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02979.x · Cited by 134
Sarnataro, D., Pisanti, S., Santoro, A., Gazzerro, P., Malfitano, A. M., Laezza, C., & Bifulco, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025601 · Cited by 134
An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in mice
Izzo, A. A., Capasso, F., Costagliola, A., Bisogno, T., Marsicano, G., Ligresti, A., Matias, I., Capasso, R., Pinto, L., Borrelli, F., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00892-8 · Cited by 132
Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection
Witting, A., Chen, L., Cudaback, E., Straiker, A. J., Walter, L. M., Rickman, B. H., Möller, T., Brosnan, C. F., & Stella, N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510418103 · Cited by 130
Sipe, J. C., Arbour, N., Gerber, A., & Beutler, E. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0205111 · Cited by 127
Guo, Y. X., Wang, H., Okamoto, Y., Ueda, N., Kingsley, P. J., Marnett, L. J., Schmid, H. H. O., Das, S., & Dey, S. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500168200 · Cited by 123
Development of the first potent and specific inhibitors of endocannabinoid biosynthesis
Bisogno, T., Cascio, M. G., Saha, B., Mahadevan, A., Urbani, P., Minassi, A., Appendino, G., Saturnino, C., Martin, B. R., Razdan, R. K., et al. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.12.009 · Cited by 123
Amnesia induced by β-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade
Mazzola, C., Micale, V., & Drago, F. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.026 · Cited by 122
Barrero, F. J., Ampuero, I., Morales, B., Vives, F., Luna, J. D. D., Hoenicka, J., & de Yébenes, J. G. (2005) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500301 · Cited by 117
Multiple Mechanisms of Endocannabinoid Response Initiation in Hippocampus
Edwards, D. A., Kim, J., & Alger, B. E. (2005) · Journal of Neurophysiology · doi:10.1152/jn.00813.2005 · Cited by 116
Leroy, S., Griffon, N., Bourdel, M., Olié, J., Poirier, M. F., & Krebs, M. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.10038 · Cited by 115
Maccarrone, M., Bari, M., Rienzo, M. D., Finazzi‐Agrò, A., & Rossi, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302123200 · Cited by 113
Endocannabinoids accumulate in spinal cord of SOD1G93A transgenic mice
Witting, A., Weydt, P., Hong, S. Y., Kliot, M., Möller, T., & Stella, N. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02544.x · Cited by 112
Activation of cannabinoid CB1 receptors induces glucose intolerance in rats
Bermúdez‐Silva, F. J., Serrano, A., Diaz-Molina, F. J., Sánchez-Vera, I., Juan-Picó, P., Nadal, Á., Fuentes, E., & de Fonseca, F. R. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.016 · Cited by 109
Transcriptional regulation of the mouse fatty acid amide hydrolase gene
Waleh, N. S., Cravatt, B. F., Apte-Deshpande, A. D., Terao, A., & Kilduff, T. S. (2002) · Gene · doi:10.1016/s0378-1119(02)00598-x · Cited by 104
Siegfried, Z., Kanyas, K., Latzer, Y., Karni, O., Bloch, M., Lerer, B., & Berry, E. M. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20089 · Cited by 103
Fernández‐Espejo, E., Caraballo, I., de Fonseca, F. R., Banoua, F. E., Ferrer, B., Flores, J. A., & Galán-Rodríguez, B. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.10.015 · Cited by 103
Protective activation of the endocannabinoid system during ischemia in dopamine neurons
Melis, M., Pillolla, G., Bisogno, T., Minassi, A., Petrosino, S., Perra, S., Muntoni, A. L., Lutz, B., Gessa, G. L., Marsicano, G., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.010 · Cited by 103
Self-citationKaczocha, M., Hermann, A., Glaser, S. T., Bojesen, I. N., & Deutsch, D. G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509721200 · Cited by 99
The role of the endocannabinoid system in the control of energy homeostasis
Osei‐Hyiaman, D., Harvey-White, J. D., Bátkai, S., & Kunos, G. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803276 · Cited by 98
Petersen, G. L., Sørensen, C., Schmid, P. C., Artmann, A., Tang‐Christensen, M., Hansen, S. H., Larsen, P. J., Schmid, H. H. O., & Hansen, H. S. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.12.011 · Cited by 92
Oka, S., Shin, Y., Ikeda, S., Gokoh, M., Kishimoto, S., Waku, K., Ishima, Y., & Sugiura, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413260200 · Cited by 92
Cannabinoids and the Digestive Tract
Izzo, A. A., & Coutts, A. A. (2005) · Springer eBooks · doi:10.1007/3-540-26573-2_19 · Cited by 91
McFarland, M. J., & Barker, E. L. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.07.008 · Cited by 91
Ballon, N., Leroy, S., Roy, C., Bourdel, M., Charles‐Nicolas, A., Krebs, M., & Poirier, M. F. (2005) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500352 · Cited by 86
de Lago, E., Petrosino, S., Valenti, M., Morera, E., Ortega‐Gutiérrez, S., Fernández‐Ruíz, J., & Marzo, V. D. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.05.011 · Cited by 86
Self-citationPetersen, G. L., Moesgaard, B., Schmid, P. C., Schmid, H. H. O., Broholm, H., Kosteljanetz, M., & Hansen, H. S. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03013.x · Cited by 85
Association study of a cannabinoid receptor gene (CNR1) polymorphism and schizophrenia
Tsai, S., Wang, Y.-C., & Hong, C. (2000) · Psychiatric Genetics · doi:10.1097/00041444-200010030-00008 · Cited by 83
Wettschureck, N., van der Stelt, M., Tsubokawa, H., Krestel, H. E., Moers, A., Petrosino, S., Schütz, G., Marzo, V. D., & Offermanns, S. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00397-06 · Cited by 76
Self-citationHerman, A. I., Kranzler, H. R., Cubells, J. F., et al. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30325 · Cited by 70
Guagnini, F., Valenti, M., Mukenge, S., Matias, I., Bianchetti, A., Palo, S. D., Ferla, G., Marzo, V. D., & Croci, T. (2006) · Gut · doi:10.1136/gut.2005.076372 · Cited by 68
Ligresti, A., Cascio, M. G., Pryce, G., Kulasegram, S., Beletskaya, I., PETROCELLIS, L. D., Saha, B., Mahadevan, A., Visintin, C., Wiley, J. L., et al. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706418 · Cited by 66
Brenowitz, S. D., Best, A. R., & Regehr, W. G. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1280-06.2006 · Cited by 66
Morita, Y., Ujike, H., Tanaka, Y., Uchida, N., Nomura, A., Ohtani, K., Kishimoto, M., Morio, A., Imamura, T., Sakai, A., et al. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.11.050 · Cited by 62
Avraham, Y., Israeli, E., Gabbay, E., Okun, A., Zolotarev, O., Silberman, I., Ganzburg, V., Dagon, Y., Magen, I., Vorobia, L., et al. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.07.008 · Cited by 62
Maccarrone, M., Fride, E., Bisogno, T., Bari, M., Cascio, M. G., Battista, N., Finazzi‐Agrò, A., Suris, R., Mechoulam, R., & Marzo, V. D. (2004) · Molecular Human Reproduction · doi:10.1093/molehr/gah130 · Cited by 61
Oddi, S., Bari, M., Battista, N., Barsacchi, D., Cozzani, I., & Maccarrone, M. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4446-8 · Cited by 60
Li, T., Liu, X., Zhu, Z.-H., Zhao, J., Hu, X., Ball, D. M., Sham, P. C., & Collier, D. A. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000670 · Cited by 60
Chesterfield, A. K., Kidd, S. R., Moore, S. A., Schaus, J. M., Liu, B., Nomikos, G. G., & Felder, C. C. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9072-6 · Cited by 50
A new class of inhibitors of 2-arachidonoylglycerol hydrolysis and invasion of prostate cancer cells
Nithipatikom, K., Endsley, M. P., Isbell, M. A., Wheelock, C. E., Hammock, B. D., & Campbell, W. B. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.049 · Cited by 49
Mulder, A. M., & Cravatt, B. F. (2006) · Biochemistry · doi:10.1021/bi061122s · Cited by 45
Tourette syndrome is not caused by mutations in the central cannabinoid receptor (CNR1) gene
Gadzicki, D., Müller‐Vahl, K., Heller, D., Ossege, S., Nöthen, M. M., Hebebrand, J., & Stuhrmann, M. (2004) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20159 · Cited by 45
Alcoholism-related phenotypes and genetic variants of the CB1 receptor
Preuss, U. W., Koller, G., Zill, P., et al. (2003) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-003-0440-7 · Cited by 41
Okamoto, Y., Morishita, J., Jun, W. A. N. G., Schmid, P. C., Krebsbach, R. J., Schmid, H. H. O., & Ueda, N. (2005) · Biochemical Journal · doi:10.1042/bj20041790 · Cited by 38
Cabranes, A., Pryce, G., Baker, D., & Fernández‐Ruíz, J. (2006) · Brain Research · doi:10.1016/j.brainres.2006.06.001 · Cited by 36
URB754 Has No Effect on the Hydrolysis or Signaling Capacity of 2-AG in the Rat Brain
Saario, S. M., Palomäki, V., Lehtonen, M., Nevalainen, T., Järvinen, T., & Laitinen, J. T. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.07.008 · Cited by 34
Tsai, S., Wang, Y., & Hong, C. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1259 · Cited by 32
Preclinical science regarding cannabinoids as analgesics: An overview
Lynch, M. (2005) · Pain Research and Management · doi:10.1155/2005/169093 · Cited by 20
Cited by
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
Leweke, F. M., Piomelli, D., Pahlisch, F., Muhl, D., Gerth, C. W., Hoyer, C., Klosterkötter, J., Hellmich, M., & Koethe, D. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.15 · Cited by 1,059
Targeting the endocannabinoid system: to enhance or reduce?
Di Marzo, V. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2553 · Cited by 798
Self-citationThe Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
Ligresti, A., De Petrocellis, L., & Di Marzo, V. (2016) · Physiological Reviews · doi:10.1152/physrev.00002.2016 · Cited by 469
Self-citationSVIZENSKA, I., DUBOVY, P., & SULCOVA, A. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.05.010 · Cited by 457
Metadata
- Authors
- Di Marzo, V., & Petrosino, S.
- Venue
- Current Opinion in Lipidology
- Published
- 2007-04
- Volume
- 18
- Issue
- 2
- Pages
- 129-140
- ISSN
- 0957-9672 (ISSN-L)
- OpenAlex
- W2018115671
- Cited by
- 289
- References
- 142
- FWCI
- 21.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.